Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers

BACKGROUND: Cancer is still among the leading causes of death all over the world. Improving chemotherapy and minimizing associated toxicities are major unmet medical needs. Recently, we provided a preliminary preclinical evaluation of a human ferritin (HFt)-based drug carrier (The-0504) that selecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Fracasso, Giulio, Falvo, Elisabetta, Tisci, Giada, Sala, Gianluca, Colotti, Gianni, Cingarlini, Sara, Tito, Claudia, Bibbo, Sandra, Frusteri, Cristina, Tremante, Elisa, Giordani, Elena, Giacomini, Patrizio, Ceci, Pierpaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582389/
https://www.ncbi.nlm.nih.gov/pubmed/37860543
http://dx.doi.org/10.1016/j.heliyon.2023.e20770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582389/
https://www.ncbi.nlm.nih.gov/pubmed/37860543
http://dx.doi.org/10.1016/j.heliyon.2023.e20770

Ejemplares similares